TNFSF10 and osteosarcoma: Using a panel of human osteosarcoma cell lines, we recently observed resistance of this type of tumour cell to Apo2L/TRAIL, which could be overcome by cotreatment with chemotherapeutic agents (Evdokiou et al, 2002).